Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A

被引：0

作者：

Konkle, Barbara A. ^{[1
]}

Pasi, K. John ^{[2
]}

Perry, David J. ^{[3
]}

Mahlangu, Johnny ^{[4
]}

Rangarajan, Savita ^{[5
]}

Hanabusa, Hideji ^{[6
]}

Pabinger, Ingrid ^{[7
]}

Lethagen, Stefan ^{[8
,9
]}

Cristiano, Lynda M. ^{[10
]}

Yuan, Huixing ^{[10
]}

Pierce, Glenn F. ^{[10
]}

Allen, Geoffrey ^{[10
]}

机构：

[1] Bloodworks Northwest, Seattle, WA USA

[2] Barts & London Comprehens Care Ctr, London, England

[3] Addenbrookes Hosp, Cambridge, England

[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa

[5] Hampshire Hosp NHS Trust, Basingstoke, Hants, England

[6] Ogikubo Hosp, Tokyo, Japan

[7] Med Univ Wien, Vienna, Austria

[8] Sobi, Stockholm, Sweden

[9] Univ Copenhagen, Copenhagen, Denmark

[10] Biogen, Cambridge, MA USA

来源：

HAEMOPHILIA | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：44 / 44

页数：1

共 50 条

[41] Perioperative Management Of Subjects With Haemophilia A In The ASPIRE Study With Long-acting Recombinant Factor VIII FC Fusion Protein (rFVIIIFc)
Mahlangu, J.
Ragni, M.
Gupta, N.
Rangarajan, S.
Nogami, K.
Li, X.
Allen, G.
Pierce, G. F.
Robinson, B.
HAEMOPHILIA, 2015, 21 : 82 - 82
[42] Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
Powell, Jerry S.
Josephson, Neil C.
Quon, Doris
Ragni, Margaret V.
Cheng, Gregory
Li, Ella
Jiang, Haiyan
Li, Lian
Dumont, Jennifer A.
Goyal, Jaya
Zhang, Xin
Sommer, Jurg
McCue, Justin
Barbetti, Margaret
Luk, Alvin
Pierce, Glenn F.
BLOOD, 2012, 119 (13) : 3031 - 3037
[43] Recombinant Fusion Factor VIII-Fc Fusion Protein in Severe Haemophilia A Patients
Le Quellec, Sandra
HEMATOLOGIE, 2014, 20 (06): : 304 - 306
[44] Treatment of bleeding episodes in subjects with haemophilia A with long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in the Phase 3 A-LONG study
Ragni, M.
Josephson, N.
Mahlangu, J.
Pasi, J.
Perry, D.
Powell, J.
Shapiro, A. D.
Krassova, S.
Greblikas, F.
Nugent, K.
Brennan, A.
Luk, A.
Pierce, G. F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 928 - 929
[45] Economic Impact of Immune Tolerance Induction (ITI) with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Compared to Conventional Recombinant Factor VIII (rFVIII)
Li, Nanxin
Wilson, Koo
Botteman, Marc
Nicoloso, Daniel
Krishnan, Sangeeta
Su, Jun
BLOOD, 2018, 132
[46] MANAGED CARE ORGANIZATION BUDGET IMPACT OF ADDING RECOMBINANT FACTOR VI FC FUSION PROTEIN (RFVIIIFC) TO THE FORMULARY FOR THE TREATMENT OF HEMOPHILIA A
Buckley, B. C.
Livingston, T. P.
Eldar-Lissai, A.
Hall, E. C.
VALUE IN HEALTH, 2015, 18 (03) : A294 - A294
[47] Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
Shapiro, A. D.
Mahlangu, J. N.
Perry, D.
Pasi, J.
Quon, D. V.
Chowdary, P.
Tsao, E.
Li, S.
Innes, A.
Pierce, G. F.
Allen, G. A.
HAEMOPHILIA, 2017, 23 (03) : 392 - 399
[48] POPULATION PHARMACOKINETIC MODEL FOR RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC) VALIDATED AND OPTIMIZED FOR USE IN CHILDREN
Bukkems, L. H.
Heijdra, J. M.
Mathias, M.
Collins, P. W.
Hay, C. R. M.
Leebeek, F. W. G.
Meijer, K.
Fijnvandraat, K.
Chowdary, P.
Cnossen, M. H.
Mathot, R. A. A.
HAEMATOLOGICA, 2019, 104 : 14 - 14
[49] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) in adults/adolescents with hemophilia B: Longitudinal analysis of B-LONG and B-YOND
Mahlangu, Johnny
Ragni, Margaret V.
Shapiro, Amy D.
Pasi, K. John
Ozelo, Margareth C.
Oldenburg, Johannes
Matsushita, Tadashi
Baker, Ross I.
Feng, Ingyuan
Ferrante, Francesca
Ramirez-Santiago, Alejandra
Mei, Baisong
Barnowski, Chris
HAEMOPHILIA, 2016, 22 : 47 - 47
[50] Switching toward the use of recombinant factor VIII Fc fusion protein Study among 30 patients with severe hemophilia A
Sattler, Laurent
Raissi, Ahlem
Fornoff, Damien
Gerout, Anne-Cecile
Feugeas, Olivier
Grunebaum, Lelia
Desprez, Dominique
ANNALES DE BIOLOGIE CLINIQUE, 2020, 78 (01) : 35 - 46

← 1 2 3 4 5 →